Anne C Lewin

Title: The Innovative Contributions of Anne C. Lewin

Introduction

Anne C. Lewin is a prominent inventor based in Lawrenceville, NJ (US). She has made significant contributions to the field of cancer diagnostics through her innovative work. With a total of 2 patents, her research focuses on developing diagnostic antibodies that can aid in cancer treatment.

Latest Patents

Among her latest patents is the development of anti-GITR antibodies for cancer diagnostics. These antibodies bind to glucocorticoid-induced tumor necrosis factor receptor (GITR). They are instrumental in detecting the expression of GITR in biological samples, such as tumor tissue. This innovation helps identify cancer patients who are likely to respond to anti-GITR immunotherapy, thereby predicting treatment outcomes.

Career Highlights

Anne C. Lewin is currently associated with Bristol-Myers Squibb Company, where she continues to advance her research in cancer diagnostics. Her work is pivotal in enhancing the understanding of cancer treatment and improving patient outcomes.

Collaborations

She collaborates with esteemed colleagues, including Xi-Tao Wang and Olufemi A. Adelakun, to further her research initiatives. Their combined expertise contributes to the development of groundbreaking diagnostic tools.

Conclusion

Anne C. Lewin's innovative work in cancer diagnostics exemplifies the impact of research and collaboration in the medical field. Her contributions are vital for improving cancer treatment and patient care.